beta-lactorphin has been researched along with Osteoporosis, Postmenopausal in 1 studies
*Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapila, R; Kapila, S; Karvande, A; Pandey, M; Trivedi, R | 1 |
1 other study(ies) available for beta-lactorphin and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Evaluation of the osteoprotective potential of whey derived-antioxidative (YVEEL) and angiotensin-converting enzyme inhibitory (YLLF) bioactive peptides in ovariectomised rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Cancellous Bone; Dietary Supplements; Female; Humans; Inflammation Mediators; Oligopeptides; Osteoporosis, Postmenopausal; Ovariectomy; Peptide Fragments; Random Allocation; Rats, Wistar; Tomography, X-Ray Computed; Whey Proteins | 2018 |